JenPlateau said:It is worth asking what the claim would look like if it were false.
Agreed on the substance. I would put less weight on the timescale, because two months of anything is not enough to distinguish a trend from a wobble.
I would rather be corrected than agreed with, if it comes to it.
pat_auckland said:ATTAIN trial (survodutide) context for liver and MASH: survodutide, a GLP-1/glucagon dual agonist, showed -18.7% body weight at 46 weeks in the Phase…
Thank you for spelling out the reasoning rather than just the conclusion. I will report back once I have actually tried it.
JenPlateau said:It is worth asking what the claim would look like if it were false.
Pushing back on JenPlateau here. I think the framing smuggles in the conclusion. Ask it the other way round and the obvious answer reverses, which usually means the question is doing the work.
Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.
Shop Reference StandardsOne concrete data point for the thread. Worth stating the units and the reference range whenever you post a number here. A large fraction of the apparent disagreement in these threads is two people using different units and both being right.